Technology Opportunities

Refine / Revise Search19 technologies found
page 1 of 1
A Novel Non-Hormonal Composition as Contraceptive for Ovulation (Tel Hashomer)
A Novel Non-Hormonal Composition as Contraceptive for Ovulation Ariel Hourvitz, Yuval Yung, Svetlana Markman and Gil Yerushalmi, Sheba Medical Center Categories Women Health , Contraceptive Composition, Fertility, Non Hormonal Development Stage Preclinical studies – efficacy and ...
More Details...
A Novel Non-Hormonal Composition as Contraceptive for Ovulation (Tel Hashomer)
A Novel Non-Hormonal Composition as Contraceptive for Ovulation Ariel Hourvitz, Yuval Yung, Svetlana Markman and Gil Yerushalmi, Sheba Medical Center Categories Women Health , Contraceptive Composition, Fertility, Non Hormonal Development Stage Preclinical studies – efficacy and ...
More Details...
Automatic decision support system for contrast enhanced spectral mammography (Tel Hashomer)
Automatic decision support system for contrast enhanced spectral mammography Dr. Miri Scalier and Dr. Arnaldo Mayer Categories Medical Imaging, Breast Cancer , Mammography, Woman Health Development Stage Prototype for clinical studies , ongoing clinical studies Patent Status ...
More Details...
Clinical support tool- Interstitial Fluid Velocity Assessment of Solid Tumors from MRI (Tel Hashomer)
Clinical support tool- Interstitial Fluid Velocity Assessment of Solid Tumors from MRI Maya Dadiani, Arnaldo Mayer & Miri Sklair-Levy, Sheba Medical Center, Israel Categories Medical imaging, Image analysis, Cancer Treatment Evaluation Development Stage First ...
More Details...
Diagnostics for early detection of ovarian cancer (Tel Hashomer)
Diagnostics for early detection of ovarian cancer Keren Levanon and Tamar Geiger, Sheba Medical Center and Tel Aviv University, Israel Categories Diagnosis, Ovarian Cancer, Development Stage Proof of concept, Efficacy Studies Patent Status Pending THM Reference ...
More Details...
Identification of Trophoblast Markers for application in (Tel Hashomer)
Identification of Trophoblast Markers for application in Non-Invasive Prenatal Diagnosis (NIPD) Dr. Esther Gurtta and Dr. Liat Abo-Gutstein, Sheba Medical Center. Categories Noninvasive Prenatal Diagnosis (NIPD), Fetal Cells in Maternal Blood Development Stage Clinical stage , ...
More Details...
Liposomal Hemin for Anticancer Treatment (Tel Hashomer)
Liposomal Hemin for Anticancer Treatment Prof. Jonathan Leor, Head of the Cardiovascular Research Institute at Tel-Aviv University and Sheba Medical Center and Prof. Margalit Rimona, The Department of Biochemistry and Molecular Biology, Tel Aviv University THE NEED Myocardial infarction (MI) ...
More Details...
MULTI-EPITOPE CITRULLINATED PEPTIDE FOR TREATMENT OF RHEUMATOID ARTHRITIS (Tel Hashomer)
Multi-Epitope Citrullinated peptide for treatment of Rheumatoid Arthritis Howard Amital, Smadar Gertel and Yehuda Shoenfeld, Sheba Medical Center, Tel Hashomer Categories Novel Composition, Immune tolerance, arthritis , Drug, Inflamation Development Stage Pre-clinical Patent ...
More Details...
Novel PAR-1-based Therapeutic Compounds for Neuro-inflammatory Diseases (Tel Hashomer)
Joav Chapman and Efrat Shavit-Stein, Sheba Medical Center, Israel Abstract Many neurological diseases are known to be associated with increased inflammation and over activation of protease activated receptors (PAR) by protein factors of the coagulation cascade. We suggest a coagulation-based ...
More Details...
Novel Composition for the treatment of Multiple Myeloma (Tel Hashomer)
Novel Composition for the treatment of Multiple Myeloma Dr Merav Laibo , Sheba Medical Center Categories Novel Drug , Multiple Sclerosis Development Stage Preclinical Patent Status Three related patent applications(2011, 2013, 2014) Background and Technology Multiple myeloma ...
More Details...
Novel Compounds for the Treatment of Liver Fibrosis/Cirrhosis (Tel Hashomer)
Novel Compounds for the Treatment of Liver Fibrosis/Cirrhosis Prof. Ziv Ben-Ari and Dr. Michal Safran, Sheba Medical Center Categories Therapeutic Composition , Liver Fibrosis, Fibrosis, drug Development Stage Preclinical Patent Status Pending THM Reference 2016045 ...
More Details...
NOVEL COMPOUNDS TO TREAT ANTIBIOTIC-RESISTANT CLINICAL ISOLATED PATHOGENS (Tel Hashomer)
Novel compounds to treat antibiotic-resistant clinical isolated pathogens Israel Nisan, Noa Tejman Yarden, Yaakov Davidov, Galia Rahav , Sheba Medical Center Categories Antibiotics, composition, drug resistant, infection disaeses, Development Stage Pre-clinical Patent ...
More Details...
Novel molecule based on aPC/EPCR PAR1 for the Treatment of Neuroinflammatory Diseases (Tel Hashomer)
Novel molecule based on aPC/EPCR PAR1 for the Treatment of Neuroinflammatory Diseases Prof. Chapman, Dr. Maggio, Dr. Shavit Stein Sheba Medical Center, Israel Categories Composition, Drug, Neuro-Inflammation, Neurodegeneration, Parkinson, Alzheimer , Multiple Sclerosis Development ...
More Details...
NOVEL TOPICAL SMALL RNA MOLECULE AS TREATMENT FOR PSORIASIS (Tel Hashomer)
Novel Topical small RNA Molecule as Treatment for Psoriasis Prof. Sidi & Dr. Avni, Sheba Medical Center, Israel Categories Psoriasis, Topical Treatment , Novel Composition, autoimmune Disease Development Stage Preclinical efficacy Patent Status Pending THM Reference ...
More Details...
PHOTO-ACTIVE BACKBONE FOR PHOTODYNAMIC THERAPY AND IMAGING (Tel Hashomer)
PHOTO-ACTIVE BACKBONE FOR PHOTODYNAMIC THERAPY AND IMAGING Genady Kostenich , Mor Herman and Arie Orenstein , Sheba Medical Center, Israel Categories Diagnostic tool for Imaging – solid cancer applications Development Stage Preclinical Efficacy Patent Status Pending THM ...
More Details...
PROCOLLAGEN C-PROTEINASE ENHANCER (PCPE) BIOMARKER FOR BONE Disease (Tel Hashomer)
PROCOLLAGEN C-PROTEINASE ENHANCER (PCPE) BIOMARKER FOR BONE Disease Shlomit Mesilaty, Ido Wolf & Anikster Yair, Sheba Medical Center, Israel Categories Biomarker Diagnostic tool for management of bone diseases Development Stage Efficacy from bone metastasis patients Patent ...
More Details...
SOMATOSTATIN BASED RECEPTOR TARGETING DRUG IN CANCER TREATMENT (Tel Hashomer)
Arie Orenstein, Mor Oron Herman, Genady Kostenich, Ehud Gazit, Yoseph Salitra, Ludmila Buzhansky, Talia Shekhter, Sheba Medical Center and Tel Aviv University, Israel Abstract Cancer has a tremendous impact on society and it is the second leading cause of death in the U.S. Current cancer ...
More Details...
THE HORMONE KLOTHO: A NOVEL THERAPY FOR BREAST AND PANCREATIC CANCERS (Tel Hashomer)
Ido Wolf, Tamar Rubinek, Bella Kaufman, Lilach Abramovitch, H. Phillip Koeffler, Chaim Sheba Medical Center, Israel Categories Biologic drug, Cancer , Breast Cancer, pancreatic cancer Development Stage Preclinical efficacy Patent Status Pending THM Reference 2011025 ...
More Details...
USE OF BILE ACIDS AND BILE SALTS TO INHIBIT BACTERIAL CONJUGATION AND ACQUISITION OF ANTIBIOTIC RESISTANCE (Tel Hashomer)
USE OF BILE ACIDS AND BILE SALTS TO INHIBIT BACTERIAL CONJUGATION AND ACQUISITION OF ANTIBIOTIC RESISTANCE O Gal Mor & G Rahav, Sheba Medical Center, Israel Categories Anti-bacterial composition, antibiotic resistance, infectious diseases Development Stage Preclinical Patent ...
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.